MRNA · Moderna, Inc.

$63.32 -0.33 (-0.52%) At close · Aug 14

Market Cap

$25.28B

399.24M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$1,677,739	—	$6,897,455	$6,897,425	$4,302,360	$157,238	$19,932,217
Stephen Hoge	President	$1,260,000	—	$9,196,606	$4,598,277	$2,983,500	$15,750	$18,054,133
James M. Mock	Chief Financial Officer	$852,192	—	$2,452,404	$1,226,205	$1,311,210	$15,750	$5,857,761
Shannon Thyme	—	$852,192	—	$2,145,838	$1,072,924	$1,311,210	$15,750	$5,397,914

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$1,625,885	—	$7,654,730	$7,654,752	$1,965,600	$975,213	$19,876,180
Shannon Thyme	—	$829,468	—	$11,507,317	$4,252,615	$763,776	$15,525	$17,368,701
Shannon Thyme Klinger	Chief Legal Officer and Corporate Secretary	$829,468	—	$11,507,317	$4,252,615	$763,776	$15,525	$17,368,701
James M. Mock	Chief Financial Officer	$826,200	—	$11,507,221	$4,252,615	$611,021	$15,525	$17,212,582
Stephen Hoge	President	$1,083,923	—	$4,422,698	$2,211,340	$1,447,992	$15,525	$9,181,478

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$1,563,462	—	$3,129,194	$9,387,713	$1,913,625	$1,074,520	$17,068,514
Stephen Hoge	President	$1,042,308	—	$2,711,792	$2,711,966	$850,500	$22,600	$7,339,166
James M. Mock	Chief Financial Officer	$792,308	—	$1,460,282	$1,460,295	$583,200	$21,100	$4,317,185
Shannon Thyme Klinger	Chief Legal Officer and Corporate Secretary	$784,616	—	$1,460,282	$1,460,295	$583,200	$24,103	$4,312,496
Shannon Thyme	—	$784,616	—	$1,460,282	$1,460,295	$583,200	$24,103	$4,312,496

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$1,423,077	—	$3,597,152	$10,791,857	$2,700,000	$851,562	$19,363,648
Stephen Hoge	President	$953,846	—	$3,117,492	$3,117,579	$1,440,000	$17,735	$8,646,652
Arpa Garay	Chief Commercial Officer	$458,462	$1,500,000	$2,502,713	$2,502,742	$508,932	$203,303	$7,676,152
James M. Mock	Chief Financial Officer	$227,885	$1,000,000	$2,919,660	$2,919,680	$259,644	$4,327	$7,331,196
Juan Andres	President,Strategic Partnerships and Enterprise Expansion	$684,616	—	$2,398,002	$2,398,166	$567,000	$26,581	$6,074,365
David Meline	Former Chief Financial Officer	$426,497	$428,055	$1,918,342	$1,918,533	—	$76,718	$4,768,145
Shannon Thyme Klinger	Chief Legal Officer and Corporate Secretary	$692,590	—	$1,112,728	$1,112,705	$756,000	$47,173	$3,721,196
Jorge Gomez	Former Chief Financial Officer Mr. Mock was hired by the Company on September 6, 2022 and was not an NEO for 2020 or 2021. Ms. Garay was hired by the Company on May 31, 2022 and was not an NEO for 2020 or 2021. Mr. Gomez was hired by the Company on May 9, 2022 and was not an NEO for 2020 or 2021. The amounts reported represent the aggregate grant date fair value of the RSUs, PSUs and stock options, respectively, awarded to our NEOs in the year ended December 31, 2022, calculated in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718. Such grant date fair values do not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the equity awards reported in these columns are set forth in Note 14 to our Consolidated Financial Statements for the year ended December 31, 2022 included in our Annual Report. The amounts reported in these columns reflect the grant date fair value for each award, and, together, differ from the targeted amounts for these grants, due to the fact that a 20-day averaging convention is used for calculating the number of RSUs, PSUs and stock options granted. The amounts reported in this column reflect the accounting cost for these awards and do not correspond to the actual economic value that may be received by the NEO upon the exercise of the stock options or any sale of the underlying shares of common stock. Mr. Gomez was involuntarily terminated from the Company on May 10, 2022, shortly after commencing employment with the Company. No bonus was paid to Mr. Gomez and he was not granted any equity awards. He was entitled to severance payments under the Amended and Restated Executive Severance Plan. See “Jorge Gomez—Executive Separation Agreement and Release” above at page 52.	$5,385	—	—	—	—	$431,668	$437,053

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$990,385	—	$3,750,000	$11,250,000	$1,500,000	$665,354	$18,155,739
Shannon Thyme Klinger	Chief Legal Officer and Corporate Secretary	$381,096	$250,000	$6,000,000	$4,000,000	$344,000	$514,051	$11,489,147
Corinne Le Goff	FormerChief Commercial Officer Mr. Meline was hired by the Company on June 8, 2020 and was not an NEO for 2019. Ms. Klinger was hired by the Company on June 1, 2021 and was not an NEO for 2019 or 2020. Dr. Le Goff was hired by the Company on January 19, 2021 and was not an NEO for 2019 or 2020. Dr. Le Goff left the Company on December 17, 2021 but remained a consultant through February 3, 2022. Under her Consulting Agreement, Dr. Le Goff remained eligible for the first tranche of her new hire equity awards (equivalent to 25%); all other tranches were forfeited.	$570,205	$300,000	$4,000,000	$4,000,000	—	$1,278,243	$10,148,448
Stephen Hoge	President	$684,808	—	$3,000,000	$3,000,000	$819,000	$299,624	$7,803,432
Juan Andres	President,Strategic Partnerships and Enterprise Expansion	$590,769	—	$2,500,000	$2,500,000	$756,000	$256,713	$6,603,482
David Meline	Former Chief Financial Officer	$616,962	—	$2,000,000	$2,000,000	$560,000	$59,312	$5,236,274

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$945,673	$1,900,000	—	$9,000,000	—	$1,009,602	$12,885,275
David Meline	Former Chief Financial Officer	$334,616	$339,344	—	$8,600,000	—	—	$9,273,960
Stephen Hoge	President	$617,366	$621,000	$1,000,000	$3,000,000	—	$24,930	$5,263,296
Tal Zaks	Chief Medical Office r	$548,712	$552,000	$750,000	$2,250,000	—	$152,269	$4,252,981
Juan Andres	President,Strategic Partnerships and Enterprise Expansion	$548,712	$662,400	$750,000	$2,250,000	—	$36,711	$4,247,823
Lorence Kim	Former Chief Financial Officer	$418,211	$145,000	—	$2,500,000	—	$330,775	$3,393,986

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$921,217	$1,017,500	—	$7,000,000	—	$9,490	$8,948,207
Stephen Hoge	President	$595,724	$396,000	—	$4,000,000	—	$9,490	$5,001,214
Tal Zaks	Chief Medical Office r	$530,630	$293,150	—	$4,000,000	—	$8,646	$4,832,426
Juan Andres	Chief Technical Operations & Quality Officer	$530,615	$322,465	—	$3,000,000	—	$9,490	$3,862,570
Lorence Kim	Former Chief Financial Officer	$560,401	$278,685	—	$2,500,000	—	$258,479	$3,597,565

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stéphane Bancel	Chief Executive Officer	$863,077	$1,800,000	—	$55,935,768	—	$9,639	$58,608,484
Lorence Kim	Former Chief Financial Officer	$542,769	$450,450	—	$7,816,512	—	$228,386	$9,038,117
Stephen Hoge	President	$570,004	$629,200	—	$3,517,431	—	$9,639	$4,726,274

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Hoge	President	$542,308	$4,400,000	—	$19,000,000	—	$9,669	$23,951,977
Lorence Kim	Chief Financial Officer	$521,154	$1,000,000	$5,470,000	$2,158,000	—	$166,633	$9,315,787
Stéphane Bancel	Chief Executive Officer	$650,769	$1,500,000	—	$4,648,000	—	$10,420	$6,809,189

Executive changes

Person	Role	Change	Effective	Filed
Michael McDonnell	Class II director	Appointed	2026-07-08	2026-07-08
Abbas Hussain	Class II director	Appointed	2024-10-02	2024-10-02
Stephen Berenson	Board of Directors	Resigned	2024-08-05	2024-07-23
David M. Rubenstein	Board of Directors	Appointed	2024-08-05	2024-07-23
Robert Langer	Board of Directors	Resigned	2024-08-05	2024-07-23
Arpa Garay	Chief Commercial Officer	Terminated	2023-12-08	2023-12-12
Jerh Collins	Chief Technical Operations and Quality Officer	Appointed	2023-01-01	2022-09-29
Juan Andres	President, Strategic Partnerships and Enterprise Expansion	Appointed	2023-01-01	2022-09-29
David Meline	Chief Financial Officer	Retired	2022-09-06	2022-08-17
James Mock	Chief Financial Officer	Appointed	2022-09-06	2022-08-17
Jorge Gomez	Chief Financial Officer	Terminated	2022-05-10	2022-05-11

Key facts CIK 1682852 CUSIP 60770K107 13F (30d) 727 filings 689 filers Visit website Investor relations